Objective Pain is among the most frequently reported, bothersome, and disabling symptoms
described by patients with osteoarthritis, rheumatoid arthritis, fibromyalgia, and other …

Objective Immune checkpoint inhibitors (ICI s) are improving prognoses in advanced stage
cancers, but they also lead to immune‐related adverse events (IRAE s). IRAE s targeting …

Studies of clinical oral health parameters, the gingival microenvironment, autoantibodies
and biomarkers, and rheumatoid arthritis disease activity measures are providing a better …

Abstract Objective The 1987 American College of Rheumatology (ACR; formerly, the
American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have …

Background Glucosamine and chondroitin sulfate are used to treat osteoarthritis. The
multicenter, double-blind, placebo-and celecoxib-controlled Glucosamine/chondroitin …

Background Lack of standardization of outcome measures limits the usefulness of clinical
trial evidence to inform health care decisions. This can be addressed by agreeing on a …

Objective To examine immunization responses in patients with rheumatoid arthritis (RA)
treated with rituximab and to investigate the effects of rituximab‐induced CD20+ B cell …

Objective Bisphosphonates have slowed the progression of osteoarthritis (OA) in animal
models and have decreased pain in states of high bone turnover. The Knee OA Structural …

Objective Osteoarthritis (OA) of the knee causes significant morbidity and current medical
treatment is limited to symptom relief, while therapies able to slow structural damage remain …

Abstract Objective The American College of Rheumatology and the European League
Against Rheumatism have developed new classification criteria for rheumatoid arthritis (RA) …